High Capacity
China’s biotech and healthcare sectors are evolving at extraordinary speed — from AI-powered “doctor avatars” and digital health super apps to a wave of Chinese drug innovation reshaping the global pharmaceutical industry. In this episode, I speak with physician and healthcare strategist Dr. Ruby Wang about the latest trends in China's AI + healthcare innovation.We discuss: * Why Western pharma companies are rushing to license Chinese drugs * China’s rise as a global biotech powerhouse * AI doctors, digital hospitals, and health super apps * The role of Alibaba, Ant Group, and DeepSeek in healthcare * Why China’s healthcare digitization is moving faster than the West * The future of AI in medicine and diagnosticsChinese medical devices, robotics, and healthcare hardware * How Chinese regulators accelerated biotech innovation * Whether healthcare can become China’s next major global export industry * The challenges China still faces in healthcare access and inequality Ruby Wang is a UK-trained physician, founder of China Health Pulse, and author of the upcoming book China Cure, which explores the global impact of China’s biotech and AI healthcare advances. Links: China Health Pulse newsletter and podcast: https://www.chinahealthpulse.com/ For transcripts and more, check out the High Capacity newsletter: https://www.highcapacity.org/ More about the host, Kyle Chan: https://www.kyleichan.com/
12 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de High Capacity!